marketcap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings DPO Ratio 2011-2025 | MEDP
Annual DPO Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 13.3 | 12.5 | 23.3 | 16 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.3 | 12.5 | 16.3 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | $ 0.33 | -6.23 % | $ 30.6 M |  Germany |
 |
Fluidigm Corporation
FLDM
|
61.4 | $ 3.75 | 1.08 % | $ 308 M |  USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | $ 2.99 | - | $ 399 M |  China |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | $ 21.99 | - | $ 562 M |  Britain |
 |
Genetron Holdings Limited
GTH
|
43.5 | $ 4.03 | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
52.5 | $ 0.46 | 0.22 % | $ 16.8 M | USA |
 |
Meridian Bioscience
VIVO
|
37.2 | $ 33.97 | - | $ 1.49 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | $ 0.48 | -20.0 % | $ 1.06 M | USA |
 |
Quotient Limited
QTNT
|
86.2 | $ 0.32 | -11.32 % | $ 1.1 M |  Schweiz |
 |
OPKO Health
OPK
|
43.1 | $ 1.32 | -1.4 % | $ 916 M | USA |
 |
Pacific Biosciences of California
PACB
|
33.5 | $ 1.76 | -0.28 % | $ 446 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | $ 165.21 | - | $ 10.7 B | USA |
 |
Heska Corporation
HSKA
|
39.7 | $ 119.99 | - | $ 1.31 B | USA |
 |
Bioventus
BVS
|
59.2 | $ 7.48 | 0.4 % | $ 469 M | USA |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 577.56 | 0.9 % | $ 221 B | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | $ 0.17 | -34.28 % | $ 263 K |  Israel |
 |
Biocept
BIOC
|
56.3 | $ 0.43 | -13.05 % | $ 7.29 M | USA |
 |
Twist Bioscience Corporation
TWST
|
15.9 | $ 31.02 | 2.48 % | $ 1.8 B | USA |
 |
Syneos Health
SYNH
|
10.1 | $ 42.98 | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
69 | $ 0.09 | - | $ 21.2 M | USA |
 |
DermTech
DMTK
|
47.4 | $ 0.09 | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
21.3 | $ 0.29 | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
52 | $ 34.72 | 5.07 % | $ 964 M | USA |
 |
DarioHealth Corp.
DRIO
|
43.9 | $ 12.88 | 3.04 % | $ 365 M | Israel |
 |
PerkinElmer
PKI
|
57.9 | $ 115.24 | -0.91 % | $ 14.7 B | USA |
 |
OpGen
OPGN
|
95 | $ 1.96 | -16.95 % | $ 1.54 M | USA |
 |
DexCom
DXCM
|
70.4 | $ 54.77 | -0.42 % | $ 21.1 B | USA |
 |
Organovo Holdings
ONVO
|
82.9 K | $ 2.12 | -2.3 % | $ 19.4 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 12.19 | 3.57 % | $ 131 M | China |
 |
Neogen Corporation
NEOG
|
62.7 | $ 6.38 | -0.39 % | $ 1.38 B | USA |
 |
Danaher Corporation
DHR
|
66.4 | $ 211.31 | 0.65 % | $ 154 B | USA |
 |
Quidel Corporation
QDEL
|
101 | $ 19.71 | -3.14 % | $ 830 M | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.46 | - | $ 5.65 M | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 27.27 | 3.45 % | $ 825 M | USA |
 |
Psychemedics Corporation
PMD
|
16 | $ 2.67 | -1.84 % | $ 15.3 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | $ 0.77 | - | $ 7.1 B |  Australia |
 |
Renalytix AI plc
RNLX
|
122 | $ 0.21 | 5.66 % | $ 22.7 M | Britain |
 |
Myriad Genetics
MYGN
|
42 | $ 6.49 | 3.02 % | $ 588 M | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.93 | -1.39 % | $ 61.9 M |  Irlanda |
 |
IQVIA Holdings
IQV
|
126 | $ 214.01 | 1.69 % | $ 38.8 B | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 16.54 | 5.86 % | $ 889 M | USA |
 |
T2 Biosystems
TTOO
|
35.9 | $ 0.12 | -39.35 % | $ 313 K | USA |
 |
Exagen
XGN
|
48.8 | $ 9.51 | -0.52 % | $ 168 M | USA |
 |
Guardant Health
GH
|
83.6 | $ 97.65 | 0.96 % | $ 12 B | USA |
 |
Agilent Technologies
A
|
50.1 | $ 146.92 | 0.12 % | $ 44.7 B | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 0.39 | -3.18 % | $ 11.4 M | USA |
 |
Lantheus Holdings
LNTH
|
25.3 | $ 50.52 | -1.08 % | $ 3.5 B | USA |